作者：
Foteini,Tsiami [1]
;
Chiara,Lago [2]
;
Noemi,Pozza [2]
;
Federica,Piccioni [3]
;
Xuesong,Zhao [4]
;
Fabienne,Lülsberg [5]
;
David E,Root [6]
;
Luca,Tiberi [2]
;
Marcel,Kool [7]
;
Jens,Schittenhelm [8]
;
Pratiti,Bandopadhayay [9]
;
Rosalind A,Segal [4]
;
Ghazaleh,Tabatabai [10]
;
Daniel J,Merk [11]
作者单位：
Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany.;Cluster of Excellence iFIT (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University, Tübingen, Germany.
[1]
Armenise-Harvard Laboratory of Brain Disorders and Cancer, CIBIO, Trento, Italy.
[2]
Genetic Perturbation Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA.;Merck Research Laboratories, Cambridge, MA, USA.
[3]
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.;Department of Neurobiology, Harvard Medical School, Boston, MA, USA.
[4]
Institute for Anatomy, Anatomy and Cell Biology, Rheinische Friedrich-Wilhelms-University, Bonn, Germany.
[5]
Genetic Perturbation Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
[6]
Hopp Children's Cancer Center (KITZ), Heidelberg, Germany.;Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Research Consortium (DKTK), Heidelberg, Germany.;Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.;University Medical Center Utrecht, Utrecht, the Netherlands.
[7]
Department of Pathology and Neuropathology, Institute of Neuropathology, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany.;Comprehensive Cancer Center Tübingen Stuttgart, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany.
[8]
Dana-Farber/Boston Children´S Cancer and Blood Disorders Center, Boston, MA, USA.;Broad Institute of MIT and Harvard, Cambridge, MA, USA.;Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
[9]
Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany.;Comprehensive Cancer Center Tübingen Stuttgart, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany.;Cluster of Excellence iFIT (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University, Tübingen, Germany.;German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Partner Site Tübingen, Heidelberg, Germany.
[10]
Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany. daniel.merk@uni-tuebingen.de.;Cluster of Excellence iFIT (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University, Tübingen, Germany. daniel.merk@uni-tuebingen.de.
[11]
DOI
10.1186/s40478-024-01831-x
PMID
39107797
发布时间
2025-01-04
换一批
换一批
